(Commission File Number) |
(IRS Employer Identification No.) |
Written Communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of Each Class |
Trading Symbol(s) |
Name of Each Exchange on Which Registered | ||
Item 9.01 |
Financial Statements and Exhibits. |
Exhibit No. |
Description of Exhibits | |
99.1 | Audited combined financial statements of the Lionsgate Studios Corp. | |
101.INS | Inline XBRL Instance Document | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
LIONSGATE STUDIOS CORP. | ||
By: |
/s/ James W. Barge | |
Name: |
James W. Barge | |
Title: |
Chief Financial Officer |
Pre-release Film Impairments | ||
Description of the Matter |
As disclosed in Note 1 to the combined financial statements, Investment in Films and Television Programs is stated at the lower of unamortized cost or estimated fair value. As disclosed in Note 3 to the combined financial statements, total impairment charges on investment in films and television programs related to theatrical films were $34.6 million for the year ended March 31, 2024 and the unamortized balance related to completed and not released and in progress theatrical films was $532.5 million at March 31, 2024. | |
Auditing the Company’s impairment evaluation for theatrical films prior to release is challenging and subjective as the key assumptions in the analysis include estimates of future anticipated revenues and box office performance, which may differ from future actual results. These estimates are based in part on the historical performance of similar films, test audience results when available, information regarding competing film releases, and critic reviews. | ||
How We Addressed the Matter in Our Audit |
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s theatrical impairment review process. For example, we tested controls over management’s review of unreleased theatrical films for indicators of impairment and management’s determination of the significant assumptions mentioned above. | |
To test the assessment of unreleased theatrical films for impairment, our audit procedures included, among others, evaluating unreleased theatrical films for indicators of impairment and testing the completeness and accuracy of the underlying data as well as the significant assumptions mentioned above. For example, we assessed management’s assumptions by comparing them to historical performance of comparable films and to current operating information, we evaluated test audience results when available, and we considered the historical accuracy of management’s estimates. We also performed sensitivity analyses to evaluate the potential changes in the expected profitability of unreleased films resulting from reasonable changes in the assumptions. |
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
ASSETS |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Accounts receivable, net |
||||||||
Due from Starz Business (Note 20) |
||||||||
Other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Investment in films and television programs, net |
||||||||
Property and equipment, net |
||||||||
Investments |
||||||||
Intangible assets, net |
||||||||
Goodwill |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
LIABILITIES |
||||||||
Accounts payable |
$ | $ | ||||||
Content related payables |
||||||||
Other accrued liabilities |
||||||||
Participations and residuals |
||||||||
Film related obligations |
||||||||
Debt - short term portion |
||||||||
Deferred revenue |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Debt |
||||||||
Participations and residuals |
||||||||
Film related obligations |
||||||||
Other liabilities |
||||||||
Deferred revenue |
||||||||
Deferred tax liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
Commitments and contingencies (Note 17) |
||||||||
Redeemable noncontrolling interests |
||||||||
EQUITY (DEFICIT) |
||||||||
Common shares, no par value, unlimited authorized, |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Accumulated other comprehensive income |
||||||||
|
|
|
|
|||||
Total parent equity (deficit) |
( |
) | ( |
) | ||||
Noncontrolling interests |
||||||||
|
|
|
|
|||||
Total equity (deficit) |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total liabilities, redeemable noncontrolling interest and equity (deficit) |
$ | $ | ||||||
|
|
|
|
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Revenues: |
||||||||||||
Revenue |
$ | $ | $ | |||||||||
Revenue - Starz Business (Note 20) |
||||||||||||
|
|
|
|
|
|
|||||||
Total revenues |
||||||||||||
Expenses: |
||||||||||||
Direct operating |
||||||||||||
Distribution and marketing |
||||||||||||
General and administration |
||||||||||||
Depreciation and amortization |
||||||||||||
Restructuring and other |
||||||||||||
|
|
|
|
|
|
|||||||
Total expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Operating income |
||||||||||||
Interest expense |
( |
) | ( |
) | ( |
) | ||||||
Interest and other income |
||||||||||||
Other expense |
( |
) | ( |
) | ( |
) | ||||||
Loss on extinguishment of debt |
( |
) | ( |
) | ( |
) | ||||||
Gain on investments, net |
||||||||||||
Equity interests income (loss) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes |
( |
) | ||||||||||
Income tax provision |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net loss |
( |
) | ( |
) | ( |
) | ||||||
Less: Net loss attributable to noncontrolling interests |
||||||||||||
|
|
|
|
|
|
|||||||
Net income (loss) attributable to Parent |
$ | ( |
) | $ | ( |
) | $ | |||||
|
|
|
|
|
|
|||||||
Per share information attributable to Parent (Note 1): |
||||||||||||
Basic net income (loss) per common share |
$ | ( |
) | $ | ( |
) | $ | |||||
|
|
|
|
|
|
|||||||
Diluted net income (loss) per common share |
$ | ( |
) | $ | ( |
) | $ | |||||
|
|
|
|
|
|
|||||||
Weighted average number of common shares outstanding (Note 1): |
||||||||||||
Basic |
||||||||||||
Diluted |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Foreign currency translation adjustments, net of tax |
( |
) | ( |
) | ( |
) | ||||||
Net unrealized gain (loss) on cash flow hedges, net of tax |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Comprehensive income (loss) |
( |
) | ||||||||||
Less: Comprehensive loss attributable to noncontrolling interests |
||||||||||||
|
|
|
|
|
|
|||||||
Comprehensive income (loss) attributable to Parent |
$ | ( |
) | $ | $ | |||||||
|
|
|
|
|
|
Common Shares |
Accumulated Deficit |
Parent Net Investment |
Accumulated Other Comprehensive Income (Loss) |
Total Parent Equity (Deficit) |
Non-controlling Interests (a) |
Total Equity (Deficit) |
||||||||||||||||||||||||||
Number |
Amount |
|||||||||||||||||||||||||||||||
(Amounts in millions) |
||||||||||||||||||||||||||||||||
Balance at March 31, 2021 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | $ | ( |
) | |||||||||||||||||
Retroactive application of recapitalization |
— | ( |
) | — | — | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at March 31, 2021, after effect of recapitalization (Note 1) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
Net income |
— | — | — | — | ||||||||||||||||||||||||||||
Net transfers from Parent |
— | — | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||
Noncontrolling interests |
— | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||
Redeemable noncontrolling interests adjustment to redemption value |
— | — | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||
Other comprehensive income |
— | — | — | — | — | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at March 31, 2022 |
$ | ( |
) | $ | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||
Net income (loss) |
— | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||||
Net transfers to Parent |
— | — | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||
Noncontrolling interests |
— | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||
Redeemable noncontrolling interests adjustment to redemption value |
— | — | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||
Other comprehensive income |
— | — | — | — | — | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at March 31, 2023 |
$ | ( |
) | $ | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||
Net income (loss) |
— | — | ( |
) | — | — | ( |
) | ( |
) | ||||||||||||||||||||||
Net transfers to Parent |
— | — | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||
Noncontrolling interests |
— | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||
Redeemable noncontrolling interests adjustment to redemption value |
— | — | ( |
) | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||
Other comprehensive loss |
— | — | — | — | ( |
) | ( |
) | — | ( |
) | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at March 31, 2024 |
$ | |
$ | ( |
) | $ | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Excludes redeemable noncontrolling interests, which are reflected in temporary equity (see Note 11). |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(As Restated) |
||||||||||||
(Amounts in millions) |
||||||||||||
Operating Activities: |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||||||
Depreciation and amortization |
||||||||||||
Amortization of films and television programs |
||||||||||||
Non-cash charge from the modification of an equity award (see Note 11) |
||||||||||||
Content and other impairments |
||||||||||||
Amortization of debt financing costs and other non-cash interest |
||||||||||||
Non-cash share-based compensation |
||||||||||||
Other amortization |
||||||||||||
Loss on extinguishment of debt |
||||||||||||
Equity interests (income) loss |
( |
) | ( |
) | ||||||||
Gain on investments, net |
( |
) | ( |
) | ( |
) | ||||||
Deferred income taxes |
( |
) | ||||||||||
Changes in operating assets and liabilities: |
||||||||||||
Proceeds from the termination of interest rate swaps |
||||||||||||
Accounts receivable, net |
( |
) | ( |
) | ||||||||
Investment in films and television programs, net |
( |
) | ( |
) | ( |
) | ||||||
Other assets |
( |
) | ( |
) | ||||||||
Accounts payable and accrued liabilities |
( |
) | ( |
) | ||||||||
Participations and residuals |
( |
) | ||||||||||
Content related payables |
( |
) | ( |
) | ||||||||
Deferred revenue |
( |
) | ( |
) | ||||||||
Due from Starz Business |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net Cash Flows Provided By (Used In) Operating Activities |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Investing Activities: |
||||||||||||
Purchase of eOne, net of cash acquired (see Note 2) |
( |
) | ||||||||||
Proceeds from the sale of equity method and other investments |
||||||||||||
Investment in equity method investees and other |
( |
) | ( |
) | ( |
) | ||||||
Distributions from equity method investees and other |
||||||||||||
Acquisition of assets (film library and related assets) |
( |
) | ||||||||||
Increase in loans receivable |
( |
) | ( |
) | ||||||||
Purchases of accounts receivables held for collateral |
( |
) | ( |
) | ( |
) | ||||||
Receipts of accounts receivables held for collateral |
||||||||||||
Capital expenditures |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net Cash Flows Provided By (Used In) Investing Activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Financing Activities: |
||||||||||||
Debt - borrowings, net of debt issuance and redemption costs |
||||||||||||
Debt - repurchases and repayments |
( |
) | ( |
) | ( |
) | ||||||
Film related obligations - borrowings |
||||||||||||
Film related obligations - repayments |
( |
) | ( |
) | ( |
) | ||||||
Settlement of financing component of interest rate swaps |
( |
) | ( |
) | ||||||||
Purchase of noncontrolling interest |
( |
) | ( |
) | ||||||||
Distributions to noncontrolling interest |
( |
) | ( |
) | ( |
) | ||||||
Parent net investment |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net Cash Flows Provided By (Used In) Financing Activities |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net Change In Cash, Cash Equivalents and Restricted Cash |
( |
) | ( |
) | ||||||||
Foreign Exchange Effects on Cash, Cash Equivalents and Restricted Cash |
( |
) | ( |
) | ||||||||
Cash, Cash Equivalents and Restricted Cash - Beginning Of Period |
||||||||||||
|
|
|
|
|
|
|||||||
Cash, Cash Equivalents and Restricted Cash - End Of Period |
$ | $ | $ | |||||||||
|
|
|
|
|
|
As Previously Reported |
Restatement Adjustment |
As Restated |
||||||||||
(Amounts in millions) |
||||||||||||
Net Cash Flows Provided by Financing Activities |
$ | $ | ( |
) | $ | |||||||
Net Change In Cash, Cash Equivalents and Restricted Cash |
$ | $ | ( |
) | $ | ( |
) | |||||
Cash, Cash Equivalents and Restricted Cash - End Of Period |
$ | $ | ( |
) | $ |
• | Theatrical. picture-by-picture |
the United States and through a sub-distributor in Canada). Revenue from the theatrical release of feature films are treated as sales or usage-based royalties, are recognized as revenue starting at the exhibition date and are based on the Company’s participation in box office receipts of the theatrical exhibitor. |
• |
Home Entertainment. |
• |
Digital Media. (pay-per-view video-on-demand |
• |
Packaged Media. Blu-ray, 4K Ultra HD, referred to as “Packaged Media”) in the retail market. Revenues are recognized, net of an allowance for estimated returns and other allowances, on the later of receipt by the customer or “street date” (when it is available for sale by the customer). |
• | Television . non-fiction programming. Television revenues include fixed fee arrangements as well as arrangements in which the Company earns advertising revenue from the exploitation of certain content on television networks. Television also includes revenue from licenses to SVOD platforms in which the initial license of a television series is to an SVOD platform or the traditional pay window for a motion picture is licensed to an SVOD platform. Revenues associated with a title, right, or window from television licensing arrangements are recognized when the feature film or television program is delivered (on an episodic basis for television product) and the window for the exploitation right has begun. |
• | International. territory-by-territory non-fiction programming. License fees and minimum guarantee amounts associated with title, window, media or territory, are recognized when access to the feature film or television program has been granted or delivery has occurred, as required under the contract, and the right to exploit the feature film or television program in that window, media or territory has commenced. Revenues are also generated from sales or usage based royalties received from international distributors based on their distribution performance pursuant to the terms of the contracts after the recoupment of certain costs in some cases, and the initial minimum guarantee, if any, and are recognized when the sale by the Company’s customer generating a royalty due to the Company has occurred. |
• |
Other. |
Computer equipment and software |
||
Furniture and equipment |
||
Leasehold improvements |
||
Land |
Year Ending March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions, except per share amounts) |
||||||||||||
Basic and Diluted Net Income (Loss) per Common Share: |
||||||||||||
Numerator: |
||||||||||||
Net income (loss) attributable to Parent |
$ | ( |
) | $ | ( |
) | $ | |||||
Accretion of redeemable noncontrolling interest |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net income (loss) attributable to Parent after accretion of redeemable noncontrolling interest |
$ | ( |
) | $ | ( |
) | $ | |||||
|
|
|
|
|
|
|||||||
Denominator: |
||||||||||||
Weighted average common shares outstanding |
||||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net loss per common share |
$ | ( |
) | $ | ( |
) | $ | |||||
|
|
|
|
|
|
(Amounts in millions) |
||||
Cash and cash equivalents |
$ | |||
Accounts receivable |
||||
Investment in films and television programs |
||||
Property and equipment |
||||
Intangible assets |
||||
Other assets (1) |
||||
Accounts payable and accrued liabilities |
( |
) | ||
Content related payable |
( |
) | ||
Participations and residuals (1) |
( |
) | ||
Film related obligations (1) |
( |
) | ||
Other liabilities and deferred revenue (1) |
( |
) | ||
|
|
|||
Preliminary fair value of net assets acquired |
||||
Goodwill |
||||
|
|
|||
Preliminary purchase price consideration |
$ | |||
|
|
(1) | Includes current and non-current amounts. |
Year Ended March 31, |
||||||||
2024 |
2023 |
|||||||
(Amounts in millions) |
||||||||
Revenues |
$ | $ | ||||||
Net income (loss) attributable Parent |
$ | ( |
) | $ |
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Investment in Films and Television Programs (1)(2) : |
||||||||
Released, net of accumulated amortization |
$ | $ | ||||||
Completed and not released |
||||||||
In progress |
||||||||
In development |
||||||||
Investment in films and television programs, net |
$ | $ | ||||||
(1) | At March 31, 2024, the unamortized balance related to completed and not released and in progress theatrical films was $ |
(2) | Production tax credits reduced total investment in films and television programs by $ |
Year Ending March 31, |
||||||||||||
2025 |
2026 |
2027 |
||||||||||
(Amounts in millions) |
||||||||||||
Estimated future amortization expense: |
||||||||||||
Released investment in films and television programs |
$ | |
$ | |
$ | |
||||||
Completed and not released investment in films and television programs |
$ |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Impairments by segment: |
||||||||||||
Included in direct operating expense (1) : |
||||||||||||
Motion Picture |
$ | |
$ | $ | ||||||||
Television Production |
||||||||||||
Impairments not included in segment operating results (2) |
||||||||||||
$ | $ | |
$ | |
||||||||
(1) | Impairments included in direct operating expense are included in the amortization expense amounts disclosed above. |
(2) | Amounts in fiscal 2024 represent development costs written off in connection with changes in strategy in the Television Production segment as a result of the acquisition of eOne which are included in restructuring and other. |
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Leasehold improvements |
$ | $ | ||||||
Property and equipment |
||||||||
Computer equipment and software |
||||||||
Less accumulated depreciation and amortization |
( |
) | ( |
) | ||||
Land |
||||||||
$ | $ | |||||||
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Investments in equity method investees |
$ | $ | ||||||
Other investments |
||||||||
$ | $ | |||||||
Motion Picture |
Television Production |
Total |
||||||||||
(Amounts in millions) |
||||||||||||
Balance as of March 31, 2023 and 2022 |
$ | $ | $ | |||||||||
Acquisition of eOne (see Note 2) |
||||||||||||
Measurement period adjustments (1) |
||||||||||||
Balance as of March 31, 2024 |
$ | $ | $ | |||||||||
(1) | Measurement period adjustments for the acquisition of eOne reflect an increase to goodwill of $ |
March 31, 2024 |
March 31, 2023 |
|||||||||||||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
|||||||||||||||||||
(Amounts in millions) |
||||||||||||||||||||||||
Finite-lived intangible assets subject to amortization: |
||||||||||||||||||||||||
Customer relationships |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Trademarks and trade names |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | |||||||||||||||||||
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Senior Credit Facilities: |
||||||||
Revolving Credit Facility |
$ | $ | ||||||
Term Loan A |
||||||||
Term Loan B |
||||||||
Total corporate debt |
||||||||
Unamortized debt issuance costs |
( |
) | ( |
) | ||||
Total debt, net |
||||||||
Less current portion |
( |
) | ( |
) | ||||
Non-current portion of debt |
$ | $ | ||||||
Maturity Date |
Year Ending March 31, |
|||||||||||||||||||||||||||||||
Debt Type |
2025 |
2026 |
2027 |
2028 |
2029 |
Thereafter |
Total |
|||||||||||||||||||||||||
(Amounts in millions) |
||||||||||||||||||||||||||||||||
Revolving Credit Facility |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
Term Loan A |
||||||||||||||||||||||||||||||||
Term Loan B |
||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||
Less aggregate unamortized debt issuance costs |
( |
) | ||||||||||||||||||||||||||||||
$ | ||||||||||||||||||||||||||||||||
• | Revolving Credit Facility & Term Loan A: |
• | Term Loan B: |
• | Revolving Credit Facility & Term Loan A: |
• | Term Loan B: |
• | Term Loan A: |
• | Term Loan B: |
• | Revolving Credit Facility, Term Loan A & Term Loan B: |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Loss on Extinguishment of Debt: |
||||||||||||
Production loan prepayment (1) |
$ | ( |
) | $ | $ | |||||||
Term Loan A prepayment |
( |
) | ||||||||||
Credit Agreement amendment (Revolving Credit Facility and Term Loan A) (2) |
( |
) | ||||||||||
Termination of a portion of Revolving Credit Facility commitments |
( |
) | ||||||||||
Term Loan B repurchases and other |
( |
) | ||||||||||
$ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
(1) | Represents issuance costs written off in connection with the early prepayment of certain production loans (see Note 8). |
(2) | See Accounting for the Credit Agreement Amendment |
• | Unamortized debt issuance costs: creditor-by-creditor |
• | Fees paid to creditors and third-party costs: |
• | Unamortized debt issuance costs, third-party costs and fees paid to creditors: creditor-by-creditor |
Year Ended March 31, 2022 |
||||||||||||
Loss on Extinguishment of Debt |
Recorded as a Reduction of Outstanding Debt Balances & Amortized Over Life of New Issuances |
Total |
||||||||||
(Amounts in millions) |
||||||||||||
Credit Agreement amendment (Revolving Credit Facility and Term Loan A): |
||||||||||||
New debt issuance costs and call premiums |
$ | $ | $ | |||||||||
Previously incurred debt issuance costs |
||||||||||||
$ | $ | $ | ||||||||||
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Film related obligations: |
||||||||
Production Loans |
$ | $ | ||||||
Production Tax Credit Facility |
||||||||
Backlog Facility and Other |
||||||||
IP Credit Facility |
||||||||
Total film related obligations |
||||||||
Unamortized issuance costs |
( |
) | ( |
) | ||||
Total film related obligations, net |
||||||||
Less current portion |
( |
) | ( |
) | ||||
Total non-current film related obligations |
$ | $ | ||||||
Year Ending March 31, |
||||||||||||||||||||||||||||
2025 |
2026 |
2027 |
2028 |
2029 |
Thereafter |
Total |
||||||||||||||||||||||
(Amounts in millions) |
||||||||||||||||||||||||||||
Production Loans |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Production Tax Credit Facility (1) |
||||||||||||||||||||||||||||
Backlog Facility and Other (1) |
||||||||||||||||||||||||||||
IP Credit Facility (2) |
||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||
Less unamortized issuance costs |
( |
) | ||||||||||||||||||||||||||
$ | ||||||||||||||||||||||||||||
(1) | The repayment dates are based on the projected future amount of collateral available under these facilities. Net advances and payments under these facilities can fluctuate depending on the amount of collateral available. |
(2) | Repayment dates are based on the projected future cash flows generated from the exploitation of the rights, subject to a minimum guaranteed payment amount, as applicable (see further information below). |
Cumulative Period From September 29, 2022 Through: |
Cumulative Minimum Guaranteed Payment Amounts |
Payment Due Date | ||
(in millions) |
||||
September 30, 2023 |
$ |
|||
September 30, 2024 |
$ |
|||
September 30, 2025 |
$ |
|||
September 30, 2026 |
$ |
|||
July 30, 2027 |
$ |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Operating lease cost (1) |
$ | $ | $ | |||||||||
Short-term lease cost (2) |
||||||||||||
Variable lease cost (3) |
||||||||||||
|
|
|
|
|
|
|||||||
Total lease cost |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | Operating lease cost amounts primarily represent the amortization of right-of-use |
(2) | Short-term lease cost primarily consists of leases of facilities and equipment associated with film and television productions and are capitalized when incurred. |
(3) | Variable lease cost primarily consists of insurance, taxes, maintenance and other operating costs. |
Category |
Balance Sheet Location |
March 31, 2024 |
March 31, 2023 |
|||||||
Operating Leases |
(Amounts in millions) |
|||||||||
Right-of-use |
Other assets - non-current |
$ | $ | |||||||
|
|
|
|
|||||||
Lease liabilities (current) |
Other accrued liabilities | $ | $ | |||||||
Lease liabilities (non-current) |
Other liabilities - non-current |
|||||||||
|
|
|
|
|||||||
$ | $ | |||||||||
|
|
|
|
March 31, 2024 |
March 31, 2023 |
|||||||
Weighted average remaining lease term (in years): |
||||||||
Operating leases |
||||||||
Weighted average discount rate: |
||||||||
Operating leases |
% | % |
Operating Leases |
||||
(Amounts in millions) |
||||
Year ending March 31, |
||||
2025 |
$ | |||
2026 |
||||
2027 |
||||
2028 |
||||
2029 |
||||
Thereafter |
||||
|
|
|||
Total lease payments |
||||
Less imputed interest |
( |
) | ||
|
|
|||
Total |
$ | |||
|
|
• | Level 1 — Quoted prices in active markets for identical assets or liabilities. |
• | Level 2 — Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3 — Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. |
March 31, 2024 |
March 31, 2023 |
|||||||||||||||||||||||
Level 1 |
Level 2 |
Total |
Level 1 |
Level 2 |
Total |
|||||||||||||||||||
(Amounts in millions) |
||||||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Forward exchange contracts (see Note 18) |
$ | — | $ | — | $ | — | $ | — | $ | $ | ||||||||||||||
Interest rate swaps (see Note 18) |
— | — | ||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Forward exchange contracts (see Note 18) |
— | ( |
) | ( |
) | — | ( |
) | ( |
) |
March 31, 2024 |
March 31, 2023 |
|||||||||||||||
(Amounts in millions) |
||||||||||||||||
Carrying Value |
Fair Value (1) |
Carrying Value |
Fair Value (1) |
|||||||||||||
(Level 2) |
(Level 2) |
|||||||||||||||
Term Loan A |
$ | $ | $ | $ | ||||||||||||
Term Loan B |
||||||||||||||||
Production Loans |
||||||||||||||||
Production Tax Credit Facility |
||||||||||||||||
Backlog Facility and Other |
||||||||||||||||
IP Credit Facility |
(1) | The Company measures the fair value of its outstanding debt and interest rate swaps using discounted cash flow techniques that use observable market inputs, such as SOFR-based yield curves, swap rates, and credit ratings (Level 2 measurements). |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Beginning balance |
$ | $ | $ | |||||||||
Net loss attributable to redeemable noncontrolling interests |
( |
) | ( |
) | ( |
) | ||||||
Noncontrolling interests discount accretion |
||||||||||||
Adjustments to redemption value |
||||||||||||
Other (1) |
( |
) | ||||||||||
Cash distributions |
( |
) | ( |
) | ( |
) | ||||||
Purchase of noncontrolling interest |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | In fiscal 2024, amounts represent the reclassification of a portion of the 3 Arts Entertainment redeemable noncontrolling interest from mezzanine equity to a liability, as further described below. |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Revenue by Type: |
||||||||||||
Motion Picture |
||||||||||||
Theatrical |
$ | $ | $ | |||||||||
Home Entertainment |
||||||||||||
Digital Media |
||||||||||||
Packaged Media |
||||||||||||
|
|
|
|
|
|
|||||||
Total Home Entertainment |
||||||||||||
Television |
||||||||||||
International |
||||||||||||
Other |
||||||||||||
|
|
|
|
|
|
|||||||
Total Motion Picture revenues (1) |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Television Production |
||||||||||||
Television |
||||||||||||
International |
||||||||||||
Home Entertainment |
||||||||||||
Digital Media |
||||||||||||
Packaged Media |
||||||||||||
Total Home Entertainment |
||||||||||||
Other |
||||||||||||
Total Television Production revenues (2) |
||||||||||||
Total revenues |
$ | $ | $ | |||||||||
(1) | Total Motion Picture revenues for the years ended March 31, 2024, 2023 and 2022, includes $ |
(2) | Total Television Production revenues for the years ended March 31, 2024, 2023 and 2022, includes $ |
Year Ending March 31, |
||||||||||||||||||||
2025 |
2026 |
2027 |
Thereafter |
Total |
||||||||||||||||
(Amounts in millions) |
||||||||||||||||||||
Remaining Performance Obligations |
$ | $ | $ | $ | $ | |||||||||||||||
March 31, 2023 |
(Benefit) provision for doubtful accounts |
Other (1) |
Uncollectible accounts written-off (2) |
March 31, 2024 |
||||||||||||||||
(Amounts in millions) |
||||||||||||||||||||
Trade accounts receivable |
$ | $ | ( |
) | $ | $ | ( |
) | $ |
(1) | Represents the provision for doubtful accounts acquired in the acquisition of eOne (see Note 2). |
(2) | Represents primarily accounts receivable previously reserved for bad debt from customers in Russia, related to Russia’s invasion of Ukraine. |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Compensation Expense: |
||||||||||||
Stock options |
$ | $ | $ | |||||||||
Restricted share units and other share-based compensation |
||||||||||||
Share appreciation rights |
||||||||||||
Total Studio employee share-based compensation expense |
||||||||||||
Corporate allocation of share-based compensation |
||||||||||||
Impact of accelerated vesting on equity awards (1) |
||||||||||||
Total share-based compensation expense |
||||||||||||
Tax impact (2) |
( |
) | ( |
) | ( |
) | ||||||
Reduction in net income |
$ | $ | $ | |||||||||
(1) | Represents the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements. |
(2) | Represents the income tax benefit recognized in the statements of operations for share-based compensation arrangements prior to the effects of changes in the valuation allowance. |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Share-Based Compensation Expense: |
||||||||||||
General and administration |
$ | $ | $ | |||||||||
Restructuring and other |
||||||||||||
$ | $ | $ | ||||||||||
Stock Options and SARs |
||||||||||||||||||||||||||||||||
Existing Class A Common Stock |
Existing Class B Common Stock |
|||||||||||||||||||||||||||||||
Number of Shares |
Weighted- Average Exercise Price |
Weighted- Average Remaining Contractual Term (years) |
Aggregate Intrinsic Value (2) |
Number of Shares |
Weighted- Average Exercise Price |
Weighted- Average Remaining Contractual Term (years) |
Aggregate Intrinsic Value (2) |
|||||||||||||||||||||||||
(Amounts in millions, except for weighted-average exercise price and years) |
||||||||||||||||||||||||||||||||
Outstanding at March 31, 2023 |
$ | $ | ||||||||||||||||||||||||||||||
Granted |
— | $ | — | $ | ||||||||||||||||||||||||||||
Exercised |
— | (1) |
$ | ( |
) | $ | ||||||||||||||||||||||||||
Forfeited or expired |
( |
) | $ | ( |
) | $ | ||||||||||||||||||||||||||
Outstanding at March 31, 2024 |
$ | $ | $ | $ | ||||||||||||||||||||||||||||
Vested or expected to vest at March 31, 2024 |
$ | $ | $ | $ | ||||||||||||||||||||||||||||
Exercisable at March 31, 2024 |
$ | $ | $ | $ | ||||||||||||||||||||||||||||
(1) | Represents less than |
(2) | The intrinsic value is calculated for each in the money stock option and SAR as the difference between the closing price of Lionsgate’s common stock on March 31, 2024 and the exercise price. |
Year Ended March 31, | ||||||
2024 |
2023 |
2022 | ||||
Weighted average fair value of grants |
$ |
$ |
$ | |||
Weighted average assumptions: |
||||||
Risk-free interest rate (1) |
||||||
Expected option lives (in years) (2) |
||||||
Expected volatility for options (3) |
||||||
Expected dividend yield (4) |
(1) | The risk-free rate assumed in valuing the options is based on the U.S. Treasury Yield curve in effect applied against the expected term of the option at the time of the grant. |
(2) | The expected term of options granted represents the period of time that options granted are expected to be outstanding. |
(3) | Expected volatilities are based on implied volatilities from traded options on Lionsgate’s shares, historical volatility of Lionsgate’s shares and other factors. |
(4) | The expected dividend yield is estimated by dividing the expected annual dividend by the market price of Lionsgate’s shares at the date of grant. |
Restricted Share Units and Restricted Stock |
||||||||||||||||
Existing Class A Common Stock |
Weighted- Average Grant- Date Fair Value |
Existing Class B Common Stock |
Weighted- Average Grant- Date Fair Value |
|||||||||||||
(Amounts in millions, except for weighted-average grant date fair value) |
||||||||||||||||
Outstanding at March 31, 2023 |
(1) |
$ | $ | |||||||||||||
Granted |
$ | $ | ||||||||||||||
Vested |
(1) |
$ | ( |
) | $ | |||||||||||
Forfeited |
$ | ( |
) | $ | ||||||||||||
Outstanding at March 31, 2024 |
$ | $ | ||||||||||||||
(1) | Represents less than |
Total Unrecognized Compensation Cost |
Weighted Average Remaining Years |
|||||||
(Amounts in millions) |
||||||||
Stock Options |
$ | |||||||
Restricted Share Units and Restricted Stock |
||||||||
Total (1) |
$ | |||||||
(1) | Represents remaining unrecognized compensation cost related to the Company’s employees and an allocation of compensation costs for Lionsgate corporate and shared service employees. |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
United States |
$ | ( |
) | $ | ( |
) | $ | |||||
International |
( |
) | ||||||||||
$ | ( |
) | $ | $ | ||||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Current provision: |
||||||||||||
Federal |
$ | $ | $ | |||||||||
States |
( |
) | ||||||||||
International |
||||||||||||
Total current provision |
$ | $ | ||||||||||
Deferred provision: |
||||||||||||
Federal |
( |
) | ||||||||||
States |
( |
) | ||||||||||
International |
( |
) | ||||||||||
Total deferred provision |
( |
) | ||||||||||
Total provision for income taxes |
$ | $ | $ | |||||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Income taxes computed at Federal statutory rate |
$ | ( |
) | $ | $ | |||||||
Foreign operations subject to different income tax rates |
||||||||||||
State income tax |
( |
) | ||||||||||
Remeasurements of originating deferred tax assets and liabilities |
( |
) | ( |
) | ||||||||
Permanent differences |
||||||||||||
Nondeductible share-based compensation |
( |
) | ||||||||||
Nondeductible officers compensation |
||||||||||||
Non-controlling interest in partnerships |
||||||||||||
Foreign derived intangible income |
( |
) | ( |
) | ||||||||
Other |
||||||||||||
Changes in valuation allowance |
( |
) | ||||||||||
Total provision for income taxes |
$ | $ | $ | |||||||||
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Deferred tax assets: |
||||||||
Net operating losses |
$ | $ | ||||||
Foreign tax credits |
||||||||
Intangible assets |
||||||||
Accrued compensation |
||||||||
Operating leases- liabilities |
||||||||
Other assets |
||||||||
Reserves |
||||||||
Interest |
||||||||
Total deferred tax assets |
||||||||
Valuation allowance |
( |
) | ( |
) | ||||
Deferred tax assets, net of valuation allowance |
||||||||
Deferred tax liabilities: |
||||||||
Intangible assets |
( |
) | ||||||
Investment in film and television programs |
( |
) | ( |
) | ||||
Unrealized gains on derivative contracts |
( |
) | ( |
) | ||||
Operating leases - assets |
( |
) | ( |
) | ||||
Other |
( |
) | ( |
) | ||||
Total deferred tax liabilities |
( |
) | ( |
) | ||||
Net deferred tax liabilities |
$ | ( |
) | $ | ( |
) | ||
Amounts in millions |
||||
Gross unrecognized tax benefits at March 31, 2021 |
$ | |||
Increases related to current year tax position |
||||
Increases related to prior year tax positions |
||||
Decreases related to prior year tax positions |
||||
Settlements |
||||
Lapse in statute of limitations |
||||
Gross unrecognized tax benefits at March 31, 2022 |
||||
Increases related to current year tax position |
||||
Increases related to prior year tax positions |
||||
Decreases related to prior year tax positions |
||||
Settlements |
||||
Lapse in statute of limitations |
( |
) | ||
Gross unrecognized tax benefits at March 31, 2023 |
||||
Increases related to current year tax position |
||||
Increases related to prior year tax positions |
||||
Decreases related to prior year tax positions |
||||
Settlements |
||||
Lapse in statute of limitations |
( |
) | ||
Gross unrecognized tax benefits at March 31, 2024 |
$ | |||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Restructuring and other: |
||||||||||||
Content and other impairments (1) |
$ | $ | $ | |||||||||
Severance (2) |
||||||||||||
Cash |
||||||||||||
Accelerated vesting on equity awards (see Note 13) |
||||||||||||
Total severance costs |
||||||||||||
COVID-19 related charges included in restructuring and other |
||||||||||||
Transaction and other costs (3) |
||||||||||||
Total Restructuring and Other |
||||||||||||
Other unusual charges not included in restructuring and other or the Company’s operating segments: |
||||||||||||
Content charges included in direct operating expense (4) |
||||||||||||
COVID-19 related charges (benefit) included in direct operating expense(5) |
( |
) | ( |
) | ( |
) | ||||||
Charges related to Russia’s invasion of Ukraine included in direct operating expense (6) |
||||||||||||
Total restructuring and other and other unusual charges not included in restructuring and other |
$ | $ | $ | |||||||||
(1) | Amounts in the fiscal year ended March 31, 2024 include $ right-of-use |
(2) | Severance costs in the fiscal years ended March 31, 2024, 2023 and 2022 were primarily related to restructuring activities and other cost-saving initiatives. In fiscal 2024, amounts were due to restructuring activities including integration of the acquisition of eOne and our Motion Picture and Television Production segment. |
(3) | Amounts in the fiscal years ended March 31, 2024, 2023 and 2022 reflect transaction, integration and legal costs associated with certain strategic transactions, and restructuring activities and also include costs and benefits associated with legal and other matters. In fiscal 2024, these amounts include $ |
amounts previously expensed. See Note 11 for further information. In addition, transaction and other costs in fiscal 2024 includes approximately $ |
(4) | Amounts represent certain unusual content charges. In the fiscal year ended March 31, 2023, the amounts represent development costs written off as a result of changes in strategy across the Company’s theatrical slate in connection with certain management changes and changes in the theatrical marketplace in the Motion Picture segment. These charges are excluded from segment results and included in amortization of investment in film and television programs in direct operating expense on the combined statement of operations. |
(5) | Amounts reflected in direct operating expense include incremental costs associated with the pausing and restarting of productions including paying/hiring certain cast and crew, maintaining idle facilities and equipment costs resulting from circumstances associated with the COVID-19 global pandemic, net of insurance recoveries of $ |
(6) | Amounts represent charges related to Russia’s invasion of Ukraine, primarily related to bad debt reserves for accounts receiva ble f rom customers in Russia, included in direct operating expense in the combined statements of operations. |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Severance liability |
||||||||||||
Beginning balance |
$ | $ | $ | |||||||||
Accruals |
||||||||||||
Severance payments |
( |
) | ( |
) | ( |
) | ||||||
Ending balance (1) |
$ | $ | $ | |||||||||
(1) | As of March 31, 2024, the remaining severance liability of approximately $ |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Segment revenues |
||||||||||||
Motion Picture |
$ | $ | $ | |||||||||
Television Production |
||||||||||||
Total revenue |
$ | $ | $ | |||||||||
Gross contribution |
||||||||||||
Motion Picture |
$ | $ | $ | |||||||||
Television Production |
||||||||||||
Total gross contribution |
||||||||||||
Segment general and administration |
||||||||||||
Motion Picture |
||||||||||||
Television Production |
||||||||||||
Total segment general and administration |
||||||||||||
Segment profit |
||||||||||||
Motion Picture |
||||||||||||
Television Production |
||||||||||||
Total segment profit |
$ | $ | $ | |||||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Company’s total segment profit |
$ | $ | $ | |||||||||
Corporate general and administrative expenses (1) |
( |
) | ( |
) | ( |
) | ||||||
Adjusted depreciation and amortization (2) |
( |
) | ( |
) | ( |
) | ||||||
Restructuring and other |
( |
) | ( |
) | ( |
) | ||||||
COVID-19 related benefit (charges) included in direct operating expense and distribution and marketing expense(3) |
||||||||||||
Content charges (4) |
( |
) | ( |
) | ||||||||
Charges related to Russia’s invasion of Ukraine (5) |
( |
) | ||||||||||
Adjusted share-based compensation expense (6) |
( |
) | ( |
) | ( |
) | ||||||
Purchase accounting and related adjustments (7) |
( |
) | ( |
) | ( |
) | ||||||
Operating income |
||||||||||||
Interest expense |
( |
) | ( |
) | ( |
) | ||||||
Interest and other income |
||||||||||||
Other expense |
( |
) | ( |
) | ( |
) | ||||||
Loss on extinguishment of debt |
( |
) | ( |
) | ( |
) | ||||||
Gain on investments, net |
||||||||||||
Equity interests income (loss) |
( |
) | ||||||||||
Income (loss) before income taxes |
$ | ( |
) | $ | $ | |||||||
(1) | Corporate general and administrative expenses reflect the allocations of certain general and administrative expenses from Lionsgate related to certain corporate and shared service functions historically provided by Lionsgate, including, but not limited to, executive oversight, accounting, tax, legal, human resources, occupancy, and other shared services (see Note 1 and Note 20). Amount excludes allocation of share-based compensation expense discussed below. The costs included in corporate general and administrative expenses represent certain corporate executive expense (such as salaries and wages for the office of the Chief Executive Officer, Chief Financial Officer, General Counsel and other corporate officers), investor relations costs, costs of maintaining corporate facilities, and other unallocated common administrative support functions, including corporate accounting, finance and financial reporting, internal and external audit and tax costs, corporate and other legal support functions, and certain information technology and human resources expense. |
(2) | Adjusted depreciation and amortization represents depreciation and amortization as presented on the combined statements of operations less the depreciation and amortization related to the non-cash fair value adjustments to property and equipment and intangible assets acquired in acquisitions which are included in the purchase accounting and related adjustments line item above, as shown in the table below: |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Depreciation and amortization |
$ | $ | $ | |||||||||
Less: Amount included in purchase accounting and related adjustments |
( |
) | ( |
) | ( |
) | ||||||
Adjusted depreciation and amortization |
$ | $ | $ | |||||||||
(3) | Amounts represent the incremental costs, if any, included in direct operating expense and distribution and marketing expense resulting from circumstances associated with the COVID-19 global pandemic, net of |
insurance recoveries. During the fiscal years ended March 31, 2024, 2023 and 2022, the Company has incurred a net benefit in direct operating expense due to insurance recoveries in excess of the incremental costs expensed in the period (see Note 15). These benefits (charges) are excluded from segment operating results. |
(4) | Content charges represent certain charges included in direct operating expense in the combined statements of operations, and excluded from segment operating results (see Note 15). |
(5) | Amounts represent charges related to Russia’s invasion of Ukraine, primarily related to bad debt reserves for accounts receivable from customers in Russia, included in direct operating expense in the combined statements of operations, and excluded from segment operating results. |
(6) | The following table reconciles total share-based compensation expense to adjusted share-based compensation expense: |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Total share-based compensation expense (i) |
$ | $ | $ | |||||||||
Less: |
||||||||||||
Amount included in restructuring and other (ii) |
( |
) | ( |
) | ||||||||
Adjusted share-based compensation |
$ | $ | $ | |||||||||
(i) | Total share-based compensation expense in the years ended March 31, 2024, 2023 and 2022 includes $ |
(ii) | Represents share-based compensation expense included in restructuring and other expenses reflecting the impact of the acceleration of vesting schedules for equity awards pursuant to certain severance arrangements. |
(7) | Purchase accounting and related adjustments primarily represent the amortization of non-cash fair value adjustments to certain assets acquired in acquisitions. The following sets forth the amounts included in each line item in the financial statements: |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Purchase accounting and related adjustments: |
||||||||||||
Direct operating |
$ | $ | $ | |||||||||
General and administrative expense (i) |
||||||||||||
Depreciation and amortization |
||||||||||||
$ | $ | $ | ||||||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Amortization of recoupable portion of the purchase price |
$ | $ | $ | |||||||||
Noncontrolling interest discount amortization |
||||||||||||
Noncontrolling equity interest in distributable earnings |
||||||||||||
$ | $ | $ | ||||||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
General and administration |
||||||||||||
Segment general and administrative expenses |
$ | $ | $ | |||||||||
Corporate general and administrative expenses |
||||||||||||
Share-based compensation expense included in general and administrative expense (1) |
||||||||||||
Purchase accounting and related adjustments |
||||||||||||
$ | $ | $ | ||||||||||
(1) | Includes share-based compensation expense related to the allocation of Lionsgate corporate and shared employee share-based compensation expenses of $ |
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Assets |
||||||||
Motion Picture |
$ | $ | ||||||
Television Production |
||||||||
Other unallocated assets (1) |
||||||||
$ | $ | |||||||
(1) | Other unallocated assets primarily consist of cash, other assets and investments. |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Acquisition of investment in films and television programs |
||||||||||||
Motion Picture |
$ | $ | $ | |||||||||
Television Production |
||||||||||||
$ | $ | $ | ||||||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Capital expenditures |
||||||||||||
Motion Picture |
$ | $ | $ | |||||||||
Television Production |
||||||||||||
Corporate (1) |
||||||||||||
$ | $ | $ | ||||||||||
(1) | Represents unallocated capital expenditures primarily related to the Company’s corporate headquarters. |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Revenue |
||||||||||||
Canada |
$ | $ | $ | |||||||||
United States |
||||||||||||
Other foreign |
||||||||||||
$ | $ | $ | ||||||||||
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Long-lived assets (1) |
||||||||
United States |
$ | $ | ||||||
Other foreign |
||||||||
$ | $ | |||||||
(1) | Long-lived assets represents total assets less the following: current assets, investments, long-term receivables, interest rate swaps, intangible assets, goodwill and deferred tax assets. |
Year Ending March 31, |
||||||||||||||||||||||||||||
2025 |
2026 |
2027 |
2028 |
2029 |
Thereafter |
Total |
||||||||||||||||||||||
(Amounts in millions) |
||||||||||||||||||||||||||||
Contractual commitments by expected repayment date (off-balance sheet arrangements) |
||||||||||||||||||||||||||||
Film related obligations commitments (1) |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Interest payments (2) |
||||||||||||||||||||||||||||
Other contractual obligations |
||||||||||||||||||||||||||||
Total future commitments under contractual obligations (3) |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
(1) | Film related obligations commitments are not reflected on the combined balance sheets as they did not then meet the criter ia fo r recognition and include the following items: |
(i) | Distribution and marketing commitments represent contractual commitments for future expenditures associated with distribution and marketing of films which the Company will distribute. The payment dates of these amounts are primarily based on the anticipated release date of the film. |
(ii) | Minimum guarantee commitments represent contractual commitments related to the purchase of film rights for pictures to be delivered in the future. |
(iii) | Production loan commitments represent amounts committed for future film production and development to be funded through production financing and recorded as a production loan liability when incurred. Future payments under these commitments are based on anticipated delivery or release dates of the related film or contractual due dates of the commitment. The amounts include estimated future interest payments associated with the commitment. |
(2) | Includes cash interest payments on the Company’s Senior Credit Facilities and film related obligations, based on the applicable SOFR interest rates at March 31, 2024, net of payments and receipts from the Company’s interest rate swaps, and excluding the interest payments on the revolving credit facility as future amounts are not fixed or determinable due to fluctuating balances and interest rates. |
(3) | Not included in the amounts above are $ |
March 31, 2024 |
||||||||||||||
Foreign Currency |
Foreign Currency Amount |
US Dollar Amount |
Weighted Average Exchange Rate Per $1 USD |
|||||||||||
(Amounts in millions) |
(Amounts in millions) |
|||||||||||||
British Pound Sterling |
in exchange for | $ | ||||||||||||
Czech Koruna |
in exchange for | $ | ||||||||||||
Euro |
in exchange for | $ | ||||||||||||
Canadian Dollar |
in exchange for | $ | ||||||||||||
Mexican Peso |
in exchange for | $ | ||||||||||||
Hungarian Forint |
in exchange for | $ | ||||||||||||
New Zealand Dollar |
in exchange for | $ |
Effective Date |
Notional Amount |
Fixed Rate Paid |
Maturity Date |
|||||||||
(in millions) |
||||||||||||
$ | ||||||||||||
$ | (1) |
|||||||||||
$ | (1) |
|||||||||||
$ | (1) |
|||||||||||
$ | (1) |
|||||||||||
$ | (1) |
|||||||||||
$ | (1) |
|||||||||||
Total |
$ | |||||||||||
(1) | Represents the re-designated swaps as described in the May 2022 Transactions section below that were previously not designated cash flow hedges at March 31, 2022 |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Derivatives designated as cash flow hedges: |
||||||||||||
Forward exchange contracts |
||||||||||||
Gain (loss) recognized in accumulated other comprehensive income (loss) |
$ | ( |
) | $ | $ | |||||||
Loss reclassified from accumulated other comprehensive income (loss) into direct operating expense |
( |
) | ( |
) | ( |
) | ||||||
Interest rate swaps |
||||||||||||
Gain recognized in accumulated other comprehensive income (loss) |
$ | $ | $ | |||||||||
Gain (loss) reclassified from accumulated other comprehensive income (loss) into interest expense |
( |
) | ||||||||||
Derivatives not designated as cash flow hedges: |
||||||||||||
Interest rate swaps |
||||||||||||
Loss reclassified from accumulated other comprehensive income (loss) into interest expense |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total direct operating expense on combined statements of operations |
$ | $ | $ | |||||||||
Total interest expense on combined statements of operations |
$ | $ | $ |
March 31, 2024 |
||||||||||||
Other Current Assets |
Other Non- Current Assets |
Other Accrued Liabilities |
||||||||||
(Amounts in millions) |
||||||||||||
Derivatives designated as cash flow hedges: |
||||||||||||
Forward exchange contracts |
$ | $ | $ | |||||||||
Interest rate swaps |
||||||||||||
Fair value of derivatives |
$ | $ | $ | |||||||||
March 31, 2023 |
||||||||||||
Other Current Assets |
Other Non- Current Assets |
Other Accrued Liabilities |
||||||||||
(Amounts in millions) |
||||||||||||
Derivatives designated as cash flow hedges: |
||||||||||||
Forward exchange contracts |
$ | $ | $ | |||||||||
Interest rate swaps |
||||||||||||
Fair value of derivatives |
$ | $ | $ | |||||||||
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash included in other current assets |
||||||||
Restricted cash included in other non-current assets |
||||||||
Total cash, cash equivalents and restricted cash |
$ | $ | ||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Carrying value of receivables transferred and derecognized |
$ | |
$ | |
$ | |
||||||
Net cash proceeds received |
||||||||||||
Loss recorded related to transfers of receivables |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Gross cash proceeds received for receivables transferred and derecognized |
$ | $ | $ | |||||||||
Less amounts from collections reinvested under revolving agreement |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from new transfers |
||||||||||||
Collections not reinvested and remitted or to be remitted |
( |
) | ( |
) | ( |
) | ||||||
Net cash proceeds received (paid or to be paid) (1) |
$ | ( |
) | $ | $ |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Carrying value of receivables transferred and derecognized (2) |
$ | $ | $ | |||||||||
Obligations recorded |
$ | $ | $ | |||||||||
Loss recorded related to transfers of receivables |
$ | $ | $ |
(1) | During the year ended March 31, 2024, the Company voluntarily repurchased $ |
(2) | Receivables net of unamortized discounts on long-term, non-interest bearing receivables. |
March 31, 2024 |
March 31, 2023 |
|||||||
(Amounts in millions) |
||||||||
Other current assets |
||||||||
Prepaid expenses and other (1) |
$ | $ | ||||||
Restricted cash |
||||||||
Contract assets (2) |
||||||||
Interest rate swap assets |
||||||||
Tax credits receivable |
||||||||
$ | $ | |||||||
Other non-current assets |
||||||||
Prepaid expenses and other |
$ | $ | ||||||
Restricted cash |
||||||||
Accounts receivable (3) |
||||||||
Contract assets (3) |
||||||||
Tax credits receivable |
||||||||
Operating lease right-of-use |
||||||||
Interest rate swap assets |
||||||||
$ | $ | |||||||
(1) | Includes home entertainment product inventory which consists of Packaged Media and is stated at the lower of cost or market value (first-in, first-out method). Costs of Packaged Media sales, including shipping and handling costs, are included in distribution and marketing expenses. |
(2) | At March 31, 2024, the current portion of contract assets includes $ |
(3) | Unamortized discounts on long-term, non-interest bearing receivables were $ |
Foreign currency translation adjustments |
Net unrealized gain (loss) on cash flow hedges |
Total |
||||||||||
(Amounts in millions) |
||||||||||||
March 31, 2021 |
$ | ( |
) | ( |
) | $ | ( |
) | ||||
Other comprehensive loss |
( |
) | ||||||||||
Reclassifications to net loss (1) |
||||||||||||
March 31, 2022 |
( |
) | ||||||||||
Other comprehensive income |
( |
) | ||||||||||
Reclassifications to net loss (1) |
||||||||||||
March 31, 2023 |
( |
) | ||||||||||
Other comprehensive income (loss) |
( |
) | ||||||||||
Reclassifications to net loss (1) |
( |
) | ( |
) | ||||||||
March 31, 2024 |
$ | ( |
) | $ | $ | |||||||
(1) | Represents a loss of $ |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Non-cash investing activities: |
||||||||||||
Accrued equity method investment |
$ | |
$ | |
$ | |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Cash paid for amounts included in the measurement of lease liabilities: |
||||||||||||
Operating cash flows for operating leases |
$ | $ | |
$ | |
|||||||
Right-of-use |
||||||||||||
Operating leases |
$ | $ | $ | |||||||||
Increase in right-of-use |
||||||||||||
Operating leases - increase in right-of-use |
$ | |
$ | $ | ||||||||
Operating leases - increase in lease liability |
$ | $ | $ |
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Cash pooling and general financing activities |
$ | ( |
) | $ | $ | ( |
) | |||||
Licensing of content (1) |
||||||||||||
Corporate reimbursements |
||||||||||||
Corporate expense allocations (excluding allocation of share-based compensation) |
||||||||||||
Funding of purchases of accounts receivables held for collateral |
( |
) | ( |
) | ( |
) | ||||||
Net transfers to (from) Parent per combined statements of cash flows |
$ | $ | $ | |||||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Share-based compensation (including allocation of share-based compensation) |
( |
) | ( |
) | ( |
) | ||||||
Other non-cash transfer |
||||||||||||
Net transfers to (from) Parent per combined statements of equity (deficit) |
$ | $ | $ | |||||||||
(1) | Reflects the settlement of amounts due from the Starz Business related to the Company’s licensing arrangements with the Starz Business. |
March 31, |
||||||||
2024 |
2023 |
|||||||
(Amounts in millions) |
||||||||
Combined Balance Sheets |
||||||||
Accounts receivable |
$ | $ | ||||||
Investment in films and television programs (1) |
||||||||
Other assets, noncurrent (1) |
||||||||
Total due from related parties |
$ | $ | ||||||
Accounts payable (2) |
$ | $ | ||||||
Other accrued liabilities (1) |
||||||||
Participations and residuals, current |
||||||||
Participations and residuals, noncurrent |
||||||||
Deferred revenue, current |
||||||||
Other liabilities (1) |
||||||||
Total due to related parties |
$ | $ | ||||||
Year Ended March 31, |
||||||||||||
2024 |
2023 |
2022 |
||||||||||
(Amounts in millions) |
||||||||||||
Combined Statements of Operations |
||||||||||||
Revenues |
$ | $ | $ | |||||||||
Direct operating expense |
$ | $ | $ | |||||||||
Distribution and marketing expense |
$ | $ | $ | |||||||||
Interest and other income |
$ | $ | $ |
(1) | As of March 31, 2023, the Company had certain operating leases related to a studio facility owned by an equity-method investee which was sold during the year ended March 31, 2024. Amounts related to these leases as of March 31, 2023 are included in the table above in investment in films and television programs, other assets - noncurrent, other accrued liabilities and other liabilities. |
(2) | Amounts primarily represent production related advances due to certain of its equity method investees. |